Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Geographic Atrophy Due to Age-Related Macular Degeneration”

5 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 5 of 5 results

Testing effectiveness (Phase 2)Looking for participantsNCT07668804
What this trial is testing

Evaluate the Safety and Effect of TO-O-1007 Intravitreal Implant in Subjects With Geographic Atrophy

Who this might be right for
Geographic Atrophy Due to Age-Related Macular Degeneration
Theratocular Biotek Co. 31
Early research (Phase 1)Looking for participantsNCT03178149
What this trial is testing

The Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
Astellas Institute for Regenerative Medicine 42
Testing effectiveness (Phase 2)Ended earlyNCT00695318
What this trial is testing

Fluocinolone Acetonide Intravitreal Inserts in Geographic Atrophy

Who this might be right for
Age-Related Macular Degeneration
Alimera Sciences 17
Testing effectiveness (Phase 2)Study completedNCT00658619
What this trial is testing

Safety and Efficacy of Brimonidine Intravitreal Implant in Patients With Geographic Atrophy Due to Age-related Macular Degeneration (AMD)

Who this might be right for
Macular Degeneration
Allergan 119
Testing effectiveness (Phase 2)Ended earlyNCT03846193
What this trial is testing

FOCUS: A Phase I/II First in Human Study to Evaluate the Safety and Efficacy of GT005 Administered in Subjects With Dry AMD

Who this might be right for
Dry Age-related Macular DegenerationMacular DegenerationRetinal Disease+4 more
Gyroscope Therapeutics Limited 56